Glibenclamide treatment in relapsed transient neonatal diabetes as a result of a KCNJ11 activating mutation (N48D)

  1. Martín-Frías, M.
  2. Colino, E.
  3. Pérez De Nanclares, G.
  4. Alonso, M.
  5. Ros, P.
  6. Barrio, R.
Journal:
Diabetic Medicine

ISSN: 0742-3071 1464-5491

Year of publication: 2009

Volume: 26

Issue: 5

Pages: 567-569

Type: Letter

DOI: 10.1111/J.1464-5491.2009.02704.X GOOGLE SCHOLAR

Sustainable development goals